The gold standard in perfusion.
No contrast.
Quantified Imaging develops the world’s leading quantification software for arterial spin labelling (ASL) perfusion MRI. Our FDA-cleared solution is available for both patient care and clinical trials.
Non-invasive
No contrast agent or radiation
Quantitative
Absolute, calibrated perfusion measures
Clinically relevant
Sensitive to early disease and treatment response
Widely applicable
From patient care to clinical trials
QASL
FDA CLEARED (K253421)
Fully automatic, DICOM-compatible software for quantifying ASL perfusion MRI. QASL delivers calibrated cerebral blood flow (CBF) and arterial transit time (ATT) maps, with automated quality reporting.
A powerful tool for brain health
ASL perfusion MRI provides unique insights across a range of neurologi al conditions, supporting diagnosis, treatment monitoring and research.
Dementia
Improve diagnostic confidence and monitor treatment response.
Neurovascular Disease
Quantitive, non-invasive assessment of cerebral perfusion.
Brain Injury
Characterise and monitor perfusion changes after TBI.
Brain Tumours
Assess tumour perfusion and support treatment planning.
Trusted by leading
researchers and clinicians
QASL has been validated in 500+ subjects an is used in patient care, clinical trials and research worldwide.
“We now include ASL as our first screen for dementia, even before blood tests”
Prof Gloria Chiang
Neuroradiologist, Weill Cornell Medicine
In collaboration with leading institutions
